Universities and Biotech Companies: together for research and development of innovative drugs
In 2030 it is estimated that 80% of new drugs will be derived from biotech.
How are Universities preparing to take up this challenge? How can we promote and enhance technology transfer between universities and biotech companies? A symposium, held at the University of Milan, compared the views and experiences of representatives from the world of research, academia and biotech companies in the pharmaceutical field. Two case studies were presented: Telethon – GSK and Telethon – Shire.
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.